Skip to main content
Jaguar Health, Inc. logo
SEC Form D filing

Jaguar Health, Inc.

Biotech · Series A · Regulation D 506(b) · CA · Filed July 1, 2026

Offering amount
$2.0M
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
July 1, 2026
Signature date
June 30, 2026
CIK
0001585608

What is a Form D filing?

A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Summary

Auto-generated

Jaguar Health, Inc. is classified as biotech based on its focus on pharmaceutical development. The California-based company raised $2,000,000, anchoring its stage at series-a.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Filing history

Jaguar Health, Inc. has filed 2 Form D filings totaling $42.8M that FormDFlow has indexed.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.